Subcutaneous Immunoglobulin (SCIG) Market Trends 2025-2034: Insights into Growth and Strategic Opportunities Ahead
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Will the Subcutaneous Immunoglobulin (SCIG) Market’s Growth Rate Evolve Over the Forecast Period to 2034?
In recent times, there has been an impressive uptick in the market size of subcutaneous immunoglobulin (SCIG). This market is expected to expand from $12.72 billion in 2024 to $14.52 billion in 2025, reflecting a compound annual growth rate (CAGR) of 14.1%. The significant growth during the historical period is due to factors such as the rising incidence of immunodeficiency disorders, an increase in patient inclination towards home-based care, improved therapeutic effectiveness, and an increase in the rates of awareness and diagnosis. Additionally, favorable reimbursement policies have also contributed to this growth.
The market size for subcutaneous immunoglobulin (SCIG) is anticipated to experience swift expansion in the approaching years. The market is projected to escalate to $24.29 billion in 2029, with a compound annual growth rate (CAGR) of 13.7%. Factors contributing to this growth during the predicted period include the rising incidence of neurological conditions, the growing number of autoimmune diseases, increased awareness and acceptance of immunoglobulin treatment, broader usages in neurology and dermatology, and healthcare facilities expansion. Key trends expected during the projected period consist of improvements in drug delivery systems, heightened demand for home infusion therapies, advancements in antibody therapy, novel techniques in formulations, and innovative enhancements in SCIG.
What Strategic Factors Are Influencing the Accelerated Growth of the Subcutaneous Immunoglobulin (SCIG) Market?
The surge in secondary immunodeficiency diseases is anticipated to drive the expansion of the subcutaneous immunoglobulin market. These are conditions characterized by a diminished or compromised immune response due to causes other than the immune system itself. Factors like aging populations, the employment of immunosuppressive therapies, and environmental toxins contribute to the rise of these diseases. Subcutaneous immunoglobulin therapy is an effective method of boosting a weakened immune system, particularly in chronic conditions like HIV or autoimmune diseases, by delivering antibodies that prevent infections and assist with the maintenance of immunological functions during treatment. For instance, statistics from the UK Health Security Agency reported in October 2023 showed a 22% increase from the previous year with 3,805 new HIV diagnoses in England in 2022. Hence, the growth in the occurrence of secondary immunodeficiency diseases is fueling the subcutaneous immunoglobulin market. The subcutaneous immunoglobulin (SCIG) market is also seeing growth due to the rise in neurological disorders. These disorders of the nervous system, which include anatomical, biochemical, or electrical disruptions in the brain, spinal cord, or peripheral nerves, are on the rise due to factors like aging populations, environmental toxins, genetic factors, and lifestyle changes. Subcutaneous immunoglobulin therapy can be especially useful for these disorders as it provides antibodies that regulate the immune response, decrease inflammation, and secure neuromuscular junctions, potentially delaying the progression of the disease and alleviating symptoms. For instance, data from the Alzheimer’s Association in March 2022 disclosed that currently 6.5 million Americans over 65 are living with Alzheimer’s dementia, and projections suggest this figure could rise to 13.8 million by 2060. Therefore, the growth in neurological disorders is enhancing the expansion of the subcutaneous immunoglobulin market.
Explore Comprehensive Insights Into The Global Subcutaneous Immunoglobulin (SCIG) Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15935&type=smp
Who Are the Influential Players Reshaping the Subcutaneous Immunoglobulin (SCIG) Market Landscape?
Major companies operating in the subcutaneous immunoglobulin (SCIG) market are:
• Pfizer Inc.
• Johnson & Johnson
• Prothena Corporation plc
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
What New and Evolving Trends Are Having a Lasting Impact on the Subcutaneous Immunoglobulin (SCIG) Market?
Leading corporations in the subcutaneous immunoglobulin market are developing a novel formulation called subcutaneous human-klhw, filled with human immune globulins (Ig) to enhance the body’s immune response. This formulation is designed for subcutaneous use, specifically to address primary immunodeficiency diseases. For example, the Spain-based pharmaceutical giant, Grifols S.A., rolled out XEMBIFY 20% subcutaneous immunoglobulin (SCIG) in March 2022, a product specifically tailored to treat primary immunodeficiency, and as such, responding to a critical healthcare need for individuals with compromised immune systems. XEMBIFY is a pre-packaged solution that simplifies the treatment routine and enhances patient convenience. With a shelf life of 24 months at room temperature, it eliminates the need for cold storage during transport and storage, and this feature makes it extremely versatile across different healthcare environments.
Secure Your Global Subcutaneous Immunoglobulin (SCIG) Market Report Now for Fast and Efficient Delivery!
Which Segments Play a Crucial Role in the Expansion of the Subcutaneous Immunoglobulin (SCIG) Market?
The subcutaneous immunoglobulin (SCIG) market covered in this report is segmented –
1) By Product Type: Immunoglobulin A (IgA), Immunoglobulin G (IgG), Immunoglobulin M (IgM)
2) By Application: Primary Immunodeficiency Disorders, Autoimmune Diseases, Neurological Disorders, Other Applications
3) By End-Use: Clinics, Hospitals, Homecare, Other End-Uses
Subsegments:
1) By Immunoglobulin A (IgA): IgA1, IgA2
2) By Immunoglobulin G (IgG): IgG1, IgG2, IgG3, IgG4
3) By Immunoglobulin M (IgM): Pentameric IgM, Hexameric IgM
Which Geographic Locations Are Critical to the Growth of the Subcutaneous Immunoglobulin (SCIG) Market?
North America was the largest region in the subcutaneous immunoglobulin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the subcutaneous immunoglobulin (SCIG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
How Do Experts Define the Scope of the Subcutaneous Immunoglobulin (SCIG) Market?
Subcutaneous immunoglobulin (SCIG) refers to a method of administering immunoglobulin therapy in which the medication is delivered under the skin, rather than into a vein. This method allows for slower absorption of the medication, reducing the risk of side effects compared to intravenous administration. SCIG is used to treat various immune deficiencies, providing a convenient and effective way to boost the immune system.
Browse Through More Similar Reports By The Business Research Company:
Immunoglobulins Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report
PD-1 and PDL1 Inhibitors/ Immune Checkpoint Inhibitors Global Market Report 2024
Immune Health Supplements Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/immune-health-supplements-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
